Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Farlutal 250 tablets
0803020H0BCABAE
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 500 suspension for injection 2.5ml vials
0803020H0BCADAB
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farlutal 500 tablets
0803020H0BCACAG
|
Farlutal | Medroxyprogesterone acetate | Malignant Disease and Immunosuppression | No data available |
|
Farydak 10mg capsules
0801050BWBBABAB
|
Farydak | Panobinostat | Malignant Disease and Immunosuppression | No data available |
|
Farydak 15mg capsules
0801050BWBBACAC
|
Farydak | Panobinostat | Malignant Disease and Immunosuppression | No data available |
|
Farydak 20mg capsules
0801050BWBBAAAA
|
Farydak | Panobinostat | Malignant Disease and Immunosuppression | No data available |
|
Fingolimod 250microgram capsules
0802040ADAAABAB
|
Fingolimod hydrochloride | Fingolimod | Malignant Disease and Immunosuppression | No data available |
|
Fludara 10mg tablets
0801030W0BBAAAA
|
Fludara | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fludara 50mg powder for solution for injection vials
0801030W0BBABAB
|
Fludara | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fludarabine phosphate 10mg tablets
0801030W0AAAAAA
|
Fludarabine phosphate | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fludarabine phosphate 50mg inj vials
0801030W0AAABAB
|
Fludarabine phosphate | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fludarabine phosphate 50mg/2ml solution for injection vials
0801030W0AAACAC
|
Fludarabine phosphate | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fluoroplex 1% cream
0801030H0BDAAAX
|
Fluoroplex | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 0.5% cream
0801030H0AAAVAV
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1.1g/44ml inj pre-filled syringes
0801030H0AABDBD
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1.2g/48ml inj pre-filled syringes
0801030H0AABEBE
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1% cream
0801030H0AAAXAX
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1g/20ml solution for injection vials
0801030H0AAAWAW
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 1g/40ml inj pre-filled syringes
0801030H0AABCBC
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 2.5g/100ml solution for infusion vials
0801030H0AAAEAE
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 2.5g/50ml solution for infusion vials
0801030H0AAATAT
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 200mg/8ml inj pre-filled syringes
0801030H0AABFBF
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 250mg capsules
0801030H0AAAAAA
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 250mg/10ml solution for injection vials
0801030H0AAAHAH
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
|
Fluorouracil 250mg/5ml solution for injection vials
0801030H0AABBBB
|
Fluorouracil (Antimetabolites) | Fluorouracil (Antimetabolites) | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.